Prevention of bacterial pneumonia in HIV infection: focus on smoking cessation

References

• Hirschtick RE, Glassroth J, Jordan MC et al. Bacterial pneumonia in persons infected with the human immunodeficiency virus. Pulmonary Complications of HIV Infection Study Group. N. Engl. J. Med.333(13), 845–851 (1995).
   PubMed Web of Science ®Google Scholar
• Feikin DR, Feldman C, Schuchat A, Janoff EN. Global strategies to prevent bacterial pneumonia in adults with HIV disease. Lancet Infect. Dis.4(7), 445–455 (2004).
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control and Prevention. 1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. JAMA269(6), 729–730 (1993).
   PubMed Web of Science ®Google Scholar
• Gordin FM, Roediger MP, Girard PM et al. Pneumonia in HIV-infected persons: increased risk with cigarette smoking and treatment interruption. Am. J. Respir. Crit. Care Med.178(6), 630–636 (2008).
   PubMed Web of Science ®Google Scholar
• Kohli R, Lo Y, Homel P et al. Bacterial pneumonia, HIV therapy, and disease progression among HIV-infected women in the HIV epidemiologic research (HER) study. Clin. Infect. Dis.43(1), 90–98 (2006).
   PubMed Web of Science ®Google Scholar
• Grubb JR, Moorman AC, Baker RK, Masur H. The changing spectrum of pulmonary disease in patients with HIV infection on antiretroviral therapy. AIDS20(8), 1095–1107 (2006).
   PubMed Web of Science ®Google Scholar
• Rodriguez-Barradas MC, Goulet J, Brown S et al. Impact of pneumococcal vaccination on the incidence of pneumonia by HIV infection status among patients enrolled in the Veterans Aging Cohort 5-Site Study. Clin. Infect. Dis.46(7), 1093–1100 (2008).
   PubMed Web of Science ®Google Scholar
• Dworkin MS, Ward JW, Hanson DL, Jones JL, Kaplan JE. Pneumococcal disease among human immunodeficiency virus-infected persons: incidence, risk factors, and impact of vaccination. Clin. Infect. Dis.32(5), 794–800 (2001).
   PubMed Web of Science ®Google Scholar
• Crothers K, Griffith TA, Mcginnis KA et al. The impact of cigarette smoking on mortality, quality of life, and comorbid illness among HIV-positive veterans. J. Gen. Intern. Med.20(12), 1142–1145 (2005).
   PubMed Web of Science ®Google Scholar
• Justice AC, Lasky E, Mcginnis KA et al. Medical disease and alcohol use among veterans with human immunodeficiency infection: a comparison of disease measurement strategies. Med. Care44(8 Suppl. 2), S52–S60 (2006).
   PubMed Web of Science ®Google Scholar
• Niaura R, Shadel WG, Morrow K, Tashima K, Flanigan T, Abrams DB. Human immunodeficiency virus infection, AIDS, and smoking cessation: the time is now. Clin. Infect. Dis.31(3), 808–812 (2000).
   PubMed Web of Science ®Google Scholar
• Drach L, Holbert T, Maher J, Fox V, Schubert S, Saddler LC. Integrating smoking cessation into HIV care. AIDS Patient Care STDS24(3), 139–140 (2010).
   PubMed Web of Science ®Google Scholar
• Crothers K, Goulet JL, Rodriguez-Barradas MC et al. Impact of cigarette smoking on mortality in HIV-positive and HIV-negative veterans. AIDS Educ. Prev.21(Suppl. 3), 40–53 (2009).
   PubMed Web of Science ®Google Scholar
• Lifson AR, Neuhaus J, Arribas JR et al. Smoking-related health risks among persons with HIV in the Strategies for Management of Antiretroviral Therapy clinical trial. Am. J. Public Health100(10), 1896–1903 (2010).
   PubMed Web of Science ®Google Scholar
• Grau I, Pallares R, Tubau F et al. Epidemiologic changes in bacteremic pneumococcal disease in patients with human immunodeficiency virus in the era of highly active antiretroviral therapy. Arch. Intern. Med.165(13), 1533–1540 (2005).
   PubMedGoogle Scholar
• Arcavi L, Benowitz NL. Cigarette smoking and infection. Arch. Intern. Med.164(20), 2206–2216 (2004).
   PubMed Web of Science ®Google Scholar
• Huttunen R, Heikkinen T, Syrjanen J. Smoking and the outcome of infection. J. Intern. Med.269(3), 258–269 (2011).
   PubMed Web of Science ®Google Scholar
• Sopori M. Effects of cigarette smoke on the immune system. Nat. Rev. Immunol.2(5), 372–377 (2002).
   PubMed Web of Science ®Google Scholar
• Elssner A, Carter JE, Yunger TM, Wewers MD. HIV-1 infection does not impair human alveolar macrophage phagocytic function unless combined with cigarette smoking. Chest125(3), 1071–1076 (2004).
   PubMed Web of Science ®Google Scholar
• Mehta H, Nazzal K, Sadikot RT. Cigarette smoking and innate immunity. Inflamm. Res.57(11), 497–503 (2008).
   PubMed Web of Science ®Google Scholar
• Michaud SE, Dussault S, Haddad P, Groleau J, Rivard A. Circulating endothelial progenitor cells from healthy smokers exhibit impaired functional activities. Atherosclerosis187(2), 423–432 (2006).
   PubMed Web of Science ®Google Scholar
• Yue WS, Wang M, Yan GH et al. Smoking is associated with depletion of circulating endothelial progenitor cells and elevated pulmonary artery systolic pressure in patients with coronary artery disease. Am. J. Cardiol.106(9), 1248–1254 (2010).
   PubMed Web of Science ®Google Scholar
• Kondo T, Hayashi M, Takeshita K et al. Smoking cessation rapidly increases circulating progenitor cells in peripheral blood in chronic smokers. Arterioscler. Thromb. Vasc. Biol.24(8), 1442–1447 (2004).
   PubMed Web of Science ®Google Scholar
• Benard A, Mercie P, Alioum A et al. Bacterial pneumonia among HIV-infected patients: decreased risk after tobacco smoking cessation. ANRS CO3 Aquitaine Cohort, 2000–2007. PLoS ONE5(1), e8896 (2010).
   PubMed Web of Science ®Google Scholar
• Crothers K, Goulet JL, Rodriguez-Barradas MC et al. Decreased awareness of current smoking among health care providers of HIV-positive compared to HIV-negative veterans. J. Gen. Intern. Med.22(6), 749–754 (2007).
   PubMed Web of Science ®Google Scholar
• Shuter J, Salmo LN, Shuter AD, Nivasch EC, Fazzari M, Moadel AB. Provider beliefs and practices relating to tobacco use in patients living with HIV/AIDS: a national survey. AIDS Behav. DOI: 10.1007/s10461-011-9891-4 (2011) (Epub ahead of print).
   Google Scholar
• Benard A, Bonnet F, Tessier JF et al. Tobacco addiction and HIV infection: toward the implementation of cessation programs. ANRS CO3 Aquitaine Cohort. AIDS Patient Care STDS21(7), 458–468 (2007).
   PubMed Web of Science ®Google Scholar
• Encrenaz G, Benard A, Rondeau V et al. Determinants of smoking cessation attempts among HIV-infected patients results from a hospital-based prospective cohort. Curr. HIV Res.8(3), 212–217 (2010).
   PubMed Web of Science ®Google Scholar
• Goldberg D, Weber KM, Orsi J et al. Smoking cessation among women with and at risk for HIV: are they quitting? J. Gen Intern. Med.25(1), 39–44 (2010).
   PubMed Web of Science ®Google Scholar
• Cummins D, Trotter G, Moussa M, Turham G. Smoking cessation for clients who are HIV-positive. Nurs. Stand.20(12), 41–47 (2005).
   PubMedGoogle Scholar
• Vidrine DJ, Arduino RC, Lazev AB, Gritz ER. A randomized trial of a proactive cellular telephone intervention for smokers living with HIV/AIDS. AIDS20(2), 253–260 (2006).
   PubMed Web of Science ®Google Scholar
• Wewers ME, Neidig JL, Kihm KE. The feasibility of a nurse-managed, peer-led tobacco cessation intervention among HIV-positive smokers. J. Assoc. Nurses AIDS Care11(6), 37–44 (2000).
   PubMedGoogle Scholar
• Lloyd-Richardson EE, Stanton CA, Papandonatos GD et al. Motivation and patch treatment for HIV+ smokers: a randomized controlled trial. Addiction104(11), 1891–1900 (2009).
   PubMed Web of Science ®Google Scholar
• Ingersoll KS, Cropsey KL, Heckman CJ. A test of motivational plus nicotine replacement interventions for HIV positive smokers. AIDS Behav.13(3), 545–554 (2009).
   PubMed Web of Science ®Google Scholar
• Petoumenos K, Worm S, Reiss P et al. Rates of cardiovascular disease following smoking cessation in patients with HIV infection: results from the D:A:D study(*). HIV Med. DOI: 10.1111/j.1468-1293.2010.00901.x. (2011) (Epub ahead of print).
   Google Scholar
• Crothers K, Huang L, Goulet JL et al. HIV infection and risk for incident pulmonary diseases in the combination antiretroviral therapy era. Am. J. Respir. Crit. Care Med.183(3), 388–395 (2011).
   PubMed Web of Science ®Google Scholar
• Diaz PT, King MA, Pacht ER et al. Increased susceptibility to pulmonary emphysema among HIV-seropositive smokers. Ann. Intern. Med.132(5), 369–372 (2000).
   PubMed Web of Science ®Google Scholar
• Cupertino AP, Wick JA, Richter KP, Mussulman L, Nazir N, Ellerbeck EF. The impact of repeated cycles of pharmacotherapy on smoking cessation: a longitudinal cohort study. Arch. Intern. Med.169(20), 1928–1930 (2009).
   PubMedGoogle Scholar
• Ellerbeck EF, Mahnken JD, Cupertino AP et al. Effect of varying levels of disease management on smoking cessation: a randomized trial. Ann. Intern. Med.150(7), 437–446 (2009).
   PubMed Web of Science ®Google Scholar